These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2693501)

  • 1. Clinical and biochemical responses to nadolol and clonidine in hyperthyroidism.
    Herman VS; Joffe BI; Kalk WJ; Panz V; Wing J; Seftel HC
    J Clin Pharmacol; 1989 Dec; 29(12):1117-20. PubMed ID: 2693501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 2-adrenergic activity is normal in patients with thyroid disease.
    Del Rio G; Zizzo G; Marrama P; Venneri MG; Della Casa L; Velardo A
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):235-9. PubMed ID: 8137523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute metabolic effects of clonidine and adenosine in man.
    Swislocki AL; Vestal RE; Reaven GM; Hoffman BB
    Horm Metab Res; 1993 Feb; 25(2):90-5. PubMed ID: 8458615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nadolol on heart rate in hyperthyroidism. A controlled trial.
    Lazarus JH; Kingswood JC; John R
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):102-6. PubMed ID: 3544631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nadolol in thyrotoxicosis.
    Peden NR; Isles TE; Stevenson IH; Crooks J
    Br J Clin Pharmacol; 1982 Jun; 13(6):835-40. PubMed ID: 6124267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing effect of nadolol on serum levels of free thyroid hormones in hyperthyroidism.
    Kashiwai T; Tada H; Tamaki H; Hidaka Y; Ito E; Iwatani Y; Amino N
    Endocr J; 1994 Dec; 41(6):717-23. PubMed ID: 7704097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans.
    Liu YL; Toubro S; Astrup A; Stock MJ
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):678-85. PubMed ID: 8574280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans.
    Weiskopf RB; Eger EI; Noorani M; Daniel M
    Anesthesiology; 1994 Dec; 81(6):1350-5. PubMed ID: 7992902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine modulation of hemodynamic and catecholamine responses associated with hypoxia or hypercapnia in dogs.
    Nishikawa T; Naito H
    Anesthesiology; 1996 Mar; 84(3):672-85. PubMed ID: 8659796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
    Veith RC; Best JD; Halter JB
    J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clonidine on central and peripheral nerve tone in primary hypertension.
    Sullivan PA; De Quattro V; Foti A; Curzon G
    Hypertension; 1986 Jul; 8(7):611-7. PubMed ID: 3721561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac and plasma catecholamine response to dynamic exercise in hyperthyroidism].
    Kitamura H; Kinugawa T; Miyakoda H; Ogino K; Tomokuni A; Saito M; Hasegawa J; Kotake H; Mashiba H
    J Cardiol; 1992; 22(1):219-25. PubMed ID: 1307569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the centrally acting agent clonidine on circulating catecholamines at rest and during exercise. Comparison with the effects of beta-blocking agents.
    Mäurer W; Hausen M; Krämer B; Kübler W
    Chest; 1983 Feb; 83(2 Suppl):366-9. PubMed ID: 6129951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
    Liang CS; Frantz RP; Suematsu M; Sakamoto S; Sullebarger JT; Fan TM; Guthinger L
    Circulation; 1991 Jul; 84(1):254-66. PubMed ID: 1676348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phenoxybenzamine on cardiovascular and plasma catecholamine responses to clonidine.
    Zweifler A; Gross M; Sisson J
    Clin Pharmacol Ther; 1983 Feb; 33(2):156-62. PubMed ID: 6822028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinic and home blood pressure levels and the role of the sympathetic nervous system in clinic-home differences.
    Saito I; Takeshita E; Hayashi S; Takenaka T; Murakami M; Saruta T; Nagano S; Sekihara T
    Am J Hypertens; 1990 Mar; 3(3):219-24. PubMed ID: 2322433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V; Felt V; Nedvídková J
    Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract]   [Full Text] [Related]  

  • 20. Sympathetic neural activation evoked by mu-receptor blockade in patients addicted to opioids is abolished by intravenous clonidine.
    Kienbaum P; Heuter T; Michel MC; Scherbaum N; Gastpar M; Peters J
    Anesthesiology; 2002 Feb; 96(2):346-51. PubMed ID: 11818767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.